Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome in children: a brief literature review.


Journal

Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo
ISSN: 1984-0462
Titre abrégé: Rev Paul Pediatr
Pays: Brazil
ID NLM: 9109353

Informations de publication

Date de publication:
2022
Historique:
received: 10 03 2021
accepted: 06 07 2021
entrez: 15 6 2022
pubmed: 16 6 2022
medline: 18 6 2022
Statut: epublish

Résumé

To describe clinical, diagnostic and therapeutic characteristics of the periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome. Literature review in the PubMed database by using specific descriptors to identify all articles published in the English language in the last three years; 38 articles were found. After performing selection of titles and abstract analysis, 13 out of the 38 articles were fully read. Relevant studies found in the references of the reviewed articles were also included. The PFAPA syndrome (Periodic Fever, Aphthous Stomatitis, Pharyngitis and cervical Adenitis) is a medical condition grouped among the periodic fever syndromes. The etiology is uncertain, but possibly multifactorial, and its symptoms are accompanied by recurrent febrile episodes although weight and height development are preserved. It is a self-limiting disease of benign course with remission of two to three years without significant interference in the patient's overall development. Treatment consists of three pillars: interruption of febrile episodes, increase in the interval between episodes, and remission. Despite several attempts to establish more sensitive and specific criteria, the diagnosis of PFAPA syndrome is still clinical and reached by exclusion, based on the modified Marshall's criteria. The most common pharmacological options for treatment include prednisolone and betamethasone; colchicine may be used as prophylaxis, and surgical treatment with tonsillectomy can be considered in selected cases.

Identifiants

pubmed: 35703722
pii: S0103-05822022000100519
doi: 10.1590/1984-0462/2022/40/2021087IN
pmc: PMC9190469
pii:
doi:

Types de publication

Journal Article

Langues

eng por

Sous-ensembles de citation

IM

Pagination

e2021087

Références

Paediatr Int Child Health. 2016 Nov;36(4):270-274
pubmed: 26256936
Pediatr Rheumatol Online J. 2018 Apr 18;16(1):27
pubmed: 29669569
BMC Pediatr. 2019 Apr 8;19(1):99
pubmed: 30961562
Acta Paediatr. 2010 Feb;99(2):178-84
pubmed: 19889105
Isr Med Assoc J. 2017 Jul;19(7):444-447
pubmed: 28786261
Mediators Inflamm. 2015;2015:570418
pubmed: 26357457
Pediatr Int. 2017 Jun;59(6):655-660
pubmed: 28207965
Eur J Pediatr. 2018 Aug;177(8):1201-1206
pubmed: 29799086
J Pediatr. 2008 Aug;153(2):298
pubmed: 18639737
J Pediatr. 1999 Jul;135(1):15-21
pubmed: 10393598
J Pediatr. 2007 Sep;151(3):289-92
pubmed: 17719940
Int J Pediatr Otorhinolaryngol. 2014 Jun;78(6):964-8
pubmed: 24746456
Clin Exp Rheumatol. 2013 Nov-Dec;31(6):980-7
pubmed: 24237762
Paediatr Drugs. 2020 Jun;22(3):243-250
pubmed: 32342289
Acta Paediatr. 2016 Oct;105(10):1140-51
pubmed: 27426283
Int J Rheum Dis. 2019 Aug;22(8):1489-1497
pubmed: 31131563
Cochrane Database Syst Rev. 2019 Dec 30;12:CD008669
pubmed: 31886897
Rheumatol Int. 2017 Jun;37(6):883-889
pubmed: 28271158
J Pediatr. 2009 Aug;155(2):250-3
pubmed: 19464029
Int J Rheum Dis. 2017 Aug;20(8):1050-1051
pubmed: 26200174
Semin Arthritis Rheum. 2016 Feb;45(4):471-4
pubmed: 26315860
Int J Pediatr Otorhinolaryngol. 2010 Nov;74(11):1203-8
pubmed: 20832871
Curr Opin Rheumatol. 2017 Sep;29(5):493-499
pubmed: 28557837
N Engl J Med. 2007 Jul 19;357(3):266-81
pubmed: 17634462
Clin Rheumatol. 2019 Jan;38(1):11-17
pubmed: 30488366
Int J Pediatr Otorhinolaryngol. 2019 Jun;121:55-57
pubmed: 30870794
Med Sci Monit. 2009 Aug;15(8):RA179-87
pubmed: 19644432
Int J Pediatr Otorhinolaryngol. 2013 Mar;77(3):362-4
pubmed: 23246421
Presse Med. 2019 Feb;48(1 Pt 2):e77-e87
pubmed: 30683466
Ann Rheum Dis. 2013 May;72(5):678-85
pubmed: 22753383
J Pediatr. 2018 Jan;192:253-255
pubmed: 29031862
Rheumatology (Oxford). 2014 Jun;53(6):1125-9
pubmed: 24505122
Inflamm Res. 2014 Oct;63(10):803-19
pubmed: 25048990
Best Pract Res Clin Rheumatol. 2014 Apr;28(2):263-76
pubmed: 24974062
Pediatr Infect Dis J. 1989 Feb;8(2):119-20
pubmed: 2704602
Acta Paediatr. 2019 Aug;108(8):1385-1392
pubmed: 30901126
Pediatr Clin North Am. 2005 Apr;52(2):577-609, vii
pubmed: 15820380
Clin Rheumatol. 2017 Feb;36(2):463-468
pubmed: 27251674
Rev Bras Reumatol Engl Ed. 2016 Jan-Feb;56(1):52-7
pubmed: 27267334
J Pediatr. 1987 Jan;110(1):43-6
pubmed: 3794885
Pediatrics. 2016 Sep;138(3):
pubmed: 27565549
J Pediatr. 2016 Dec;179:172-177.e1
pubmed: 27692464
Acta Paediatr. 2008 Aug;97(8):1090-2
pubmed: 18462461
J Immunol. 2017 Mar 1;198(5):2063-2069
pubmed: 28137891
Rheumatol Int. 2019 Jun;39(6):957-970
pubmed: 30798384
Braz J Otorhinolaryngol. 2019 Jan - Feb;85(1):78-82
pubmed: 29203159

Auteurs

Cristina Terumy Okamoto (CT)

Universidade Positivo, Curitiba, PR, Brazil.

Hanne Lise Chaves (HL)

Universidade Positivo, Curitiba, PR, Brazil.

Mateus José Schmitz (MJ)

Universidade Positivo, Curitiba, PR, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH